Skip to content
Focus Net Today

Zimbabwe Rejects ‘Lopsided’ American Health Aid Agreement Due to Data Fears

Health aid illustration
The offered US financial assistance was aimed at programmes for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has rejected a substantial US health deal valued at $367m (272 million pounds) spanning five years over Washington's insistence on confidential biological samples.

The decision came to light after a internal memorandum from December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".

An official representative has since stated that the US was seeking biological samples for research and commercial gain while refused to share the resulting advantages from any future treatments.

"We must now begin the challenging and unfortunate task of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has called for further talks to secure a deal agreeable to all parties so the nation's critical HIV programme can proceed.

Wider Background

This rejection follows a similar situation in Kenya, where a court suspended a similar deal with the US after concerns were filed about the safety of citizens' health data.

Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.

USAID had managed aid for the American government, but Trump stated its spending was "inefficient" and his government was seeking government-to-government deals to boost openness and responsibility.

According to statements, 16 African countries have to date signed these new health pacts, constituting more than $18.3bn in committed funds.

Specifics of the Declined Deal

The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this cooperation might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," the Ambassador said.

However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".

"Zimbabwe was being asked to share its biological resources and data for a long time, without any equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.

"Put simply, our country would supply the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our citizens should a future health crisis emerge."

Sovereignty and International Frameworks

Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were undermining structures already set up through the international health agency.

Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.

"This framework is designed to guarantee that when a country contributes its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."

The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We welcome ongoing dialogue with our US partners on how future co-operation might be designed in a way that honours the independence and interests of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but urged that talks should continue considering a large portion of the nation's HIV programmes were funded by external financing.

"If specific concerns exist, such as those involving data governance or agreement terms, these can frequently be resolved via technical clarification and negotiated safeguards," it added.

This impasse emphasises the complex challenges between receiving vital foreign assistance and protecting local interests in an ever more data-driven world.

By

Lynn Baxter

A tech journalist with over a decade of experience covering UK digital innovations and cybersecurity trends.

Focus Net Today

Type to search articles.